In Brief
This article was originally published in The Tan Sheet
Executive Summary
Glaxo backs orlistat in light of ban request
You may also be interested in...
People In Brief
Dannenold moves up at AIDP; Pharmachem adds Bauer, Collins; Naturex founder and chairman Dikansky dies; Cyvex hires sales executives.
People In Brief
Dannenold moves up at AIDP; Pharmachem adds Bauer, Collins; Naturex founder and chairman Dikansky dies; Cyvex hires sales executives.
FDA Evaluates Alli For Potential Serious Risk Of Kidney Stones
FDA adds kidney stones to the list of potential signals of a serious risk for alli based on AER information gathered between July and October 2011. GSK, which is confident in the safety and efficacy of alli when used correctly, placed the only OTC weight-loss drug on the auction block last April, but needs a buyer.